Normalized Income after Taxes: A company's after tax profit or loss smoothed out by elimination of all non-recurring items.
InMed Pharmaceuticals Inc. (INM) had Normalized Income after Taxes of $-1.79M for the most recently reported fiscal quarter, ending 2025-06-30.
| Income Statement Financials | |
$1.30M |
|
$-1.79M |
|
$0.73M |
|
$0.58M |
|
$3.15M |
|
$-1.84M |
|
$0.05M |
|
$-1.79M |
|
$-1.79M |
|
$-1.79M |
|
$-1.79M |
|
$-1.79M |
|
|
Normalized Income after Taxes |
$-1.79M |
$-1.84M |
|
$-1.79M |
|
0.98M |
|
0.98M |
|
$51.42 |
|
$51.42 |
|
| Balance Sheet Financials | |
$12.87M |
|
$0.99M |
|
$2.71M |
|
$15.58M |
|
$1.84M |
|
$0.31M |
|
$0.31M |
|
$2.15M |
|
$13.43M |
|
$11.81M |
|
$13.43M |
|
2.00M |
|
| Cash Flow Statement Financials | |
$-7.77M |
|
-- |
|
$12.27M |
|
$6.57M |
|
$11.08M |
|
$4.50M |
|
$0.12M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
6.99 |
|
-- |
|
-- |
|
0.02 |
|
0.06 |
|
44.20% |
|
-141.19% |
|
-141.19% |
|
-- |
|
-137.07% |
|
-137.07% |
|
$-7.77M |
|
-- |
|
-- |
|
-- |
|
0.08 |
|
0.76 |
|
2.81 |
|
32.08 |
|
-13.31% |
|
-15.14% |
|
-11.48% |
|
-13.02% |
|
$6.71 |
|
$-7.96 |
|
$-7.96 |
|